Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03533036 · ClinicalTrials.gov registry record · NA
Virtual Reality Experience in First Trimester D&C
A NA study, sponsored by University of California, Los Angeles.
- Completed
- Registry status
- NA
- Development phase
- 30
- Enrollment target
NCT03533036 is a NA study that has completed, run by University of California, Los Angeles. The registered enrollment target is 30 participants.
The verdict
NCT03533036, a NA study, has completed, sponsored by University of California, Los Angeles.
- COMPLETED
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
Study Summary
Virtual reality (VR) has been used in health care settings to decrease anxiety and pain. This project is a feasibility study to evaluate whether virtual reality can be used in the setting of a first trimester pregnancy termination by D\&C and whether the use of virtual reality (VR) headsets can help decrease anxiety for patients during this procedure.
Interventions
- DEVICE applied VR headset
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2017-12-13 |
| Est. Completion | 2018-09-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03533036
The ClinicalTrials.gov registry entry for NCT03533036 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Los Angeles, which has 897 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which applied VR headset is the first listed.
NCT03533036 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03533036 about?
NCT03533036 is a clinical study titled "Virtual Reality Experience in First Trimester D&C". Virtual reality (VR) has been used in health care settings to decrease anxiety and pain. This project is a feasibility study to evaluate whether virtual reality can be used in the setting of a first trimester pregnancy termination by D\&C and whether the use of virtual reality (VR) headsets can help...
What is the current status of trial NCT03533036?
This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2017-12-13. Estimated completion is 2018-09-30.
What interventions are being tested in trial NCT03533036?
The interventions under investigation include: applied VR headset (DEVICE).
Who is sponsoring clinical trial NCT03533036?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.